Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Gynecology

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 97 articles: HTML format

Single Articles

July 2008
1. BONOME T , Levine DA, Shih J, Randonovich M, et al
   A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
   Cancer Res. 2008;68:5478-86.
   PubMed     Related articles    Abstract available
   
   
   
2. ENGELS K , Knauer SK, Loibl S, Fetz V, et al
   NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
   Cancer Res. 2008;68:5159-66.
   PubMed     Related articles    Abstract available
   
   
   
3. KIKUCHI R , Tsuda H, Kozaki K, Kanai Y, et al
   Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
   Cancer Res. 2008;68:5067-75.
   PubMed     Related articles    Abstract available
   
   
   June 2008
4. DIMPLE C , Nair SS, Rajhans R, Pitcheswara PR, et al
   Role of PELP1/MNAR signaling in ovarian tumorigenesis.
   Cancer Res. 2008;68:4902-9.
   PubMed     Related articles    Abstract available
   
   
   
5. MAYER A , Hockel M, Wree A, Leo C, et al
   Lack of hypoxic response in uterine leiomyomas despite severe tissue hypoxia.
   Cancer Res. 2008;68:4719-26.
   PubMed     Related articles    Abstract available
   
   
   
6. COWDEN DAHL KD , Symowicz J, Ning Y, Gutierrez E, et al
   Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
   Cancer Res. 2008;68:4606-13.
   PubMed     Related articles    Abstract available
   
   
   
7. ABEDINI MR , Muller EJ, Brun J, Bergeron R, et al
   Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.
   Cancer Res. 2008;68:4511-7.
   PubMed     Related articles    Abstract available
   
   
   
8. ZHANG S , Balch C, Chan MW, Lai HC, et al
   Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
   Cancer Res. 2008;68:4311-20.
   PubMed     Related articles    Abstract available
   
   
   May 2008
9. ERREN TC , Pape HG, Piekarski C, Reiter RJ, et al
   Not all shifts are equal: it's time for comprehensive exposure metrics in chronodisruption research.
   Cancer Res. 2008;68:4011.
   PubMed     Related articles   
   
   
   
10. MADELEINE MM , Johnson LG, Smith AG, Hansen JA, et al
    Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.
    Cancer Res. 2008;68:3532-9.
    PubMed     Related articles    Abstract available
    
    
    April 2008
11. SWISHER EM , Sakai W, Karlan BY, Wurz K, et al
    Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.
    Cancer Res. 2008;68:2581-6.
    PubMed     Related articles    Abstract available
    
    
    
12. BASU A , Adkins B, Basu C
    Down-regulation of caspase-2 by rottlerin via protein kinase C-delta-independent pathway.
    Cancer Res. 2008;68:2795-802.
    PubMed     Related articles    Abstract available
    
    
    
13. SHAI A , Pitot HC, Lambert PF
    p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
    Cancer Res. 2008;68:2622-31.
    PubMed     Related articles    Abstract available
    
    
    
14. KRAUS I , Driesch C, Vinokurova S, Hovig E, et al
    The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes.
    Cancer Res. 2008;68:2514-22.
    PubMed     Related articles    Abstract available
    
    
    
15. VISWANATHAN AN , Feskanich D, Schernhammer ES, Hankinson SE, et al
    Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.
    Cancer Res. 2008;68:2507-13.
    PubMed     Related articles    Abstract available
    
    
    
16. KELEMEN LE , Sellers TA, Schildkraut JM, Cunningham JM, et al
    Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.
    Cancer Res. 2008;68:2498-506.
    PubMed     Related articles    Abstract available
    
    
    
17. WANG SS , Smiraglia DJ, Wu YZ, Ghosh S, et al
    Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
    Cancer Res. 2008;68:2489-97.
    PubMed     Related articles    Abstract available
    
    
    
18. SAWADA K , Mitra AK, Radjabi AR, Bhaskar V, et al
    Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
    Cancer Res. 2008;68:2329-39.
    PubMed     Related articles    Abstract available
    
    
    
19. LOTAN T , Hickson J, Souris J, Huo D, et al
    c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Cancer Res. 2008;68:2166-75.
    PubMed     Related articles    Abstract available
    
    
    March 2008
20. JU T , Lanneau GS, Gautam T, Wang Y, et al
    Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc.
    Cancer Res. 2008;68:1636-46.
    PubMed     Related articles    Abstract available
    
    
    February 2008
21. ZECCHINI S , Bianchi M, Colombo N, Fasani R, et al
    The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium.
    Cancer Res. 2008;68:1110-8.
    PubMed     Related articles    Abstract available
    
    
    
22. JEON BH , Jang C, Han J, Kataru RP, et al
    Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer.
    Cancer Res. 2008;68:1100-9.
    PubMed     Related articles    Abstract available
    
    
    
23. POTAPOVA A , Hoffman AM, Godwin AK, Al-Saleem T, et al
    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Cancer Res. 2008;68:998-1002.
    PubMed     Related articles    Abstract available
    
    
    
24. CONTRERAS CM , Gurumurthy S, Haynie JM, Shirley LJ, et al
    Loss of Lkb1 provokes highly invasive endometrial adenocarcinomas.
    Cancer Res. 2008;68:759-66.
    PubMed     Related articles    Abstract available
    
    
    
25. KLINCK R , Bramard A, Inkel L, Dufresne-Martin G, et al
    Multiple alternative splicing markers for ovarian cancer.
    Cancer Res. 2008;68:657-63.
    PubMed     Related articles    Abstract available
    
    
    January 2008
26. YANG H , Kong W, He L, Zhao JJ, et al
    MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Cancer Res. 2008;68:425-33.
    PubMed     Related articles    Abstract available
    
    
    
27. GUNTER MJ , Hoover DR, Yu H, Wassertheil-Smoller S, et al
    Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women.
    Cancer Res. 2008;68:329-37.
    PubMed     Related articles    Abstract available
    
    
    
28. VINOKUROVA S , Wentzensen N, Kraus I, Klaes R, et al
    Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
    Cancer Res. 2008;68:307-13.
    PubMed     Related articles    Abstract available
    
    
    
29. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Related articles    Abstract available
    
    
    December 2007
30. WANG J , Zhou JY, Wu GS
    ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells.
    Cancer Res. 2007;67:11933-41.
    PubMed     Related articles    Abstract available
    
    
    
31. LI L , Ryser S, Dizin E, Pils D, et al
    Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Cancer Res. 2007;67:11876-85.
    PubMed     Related articles    Abstract available
    
    
    
32. GAITHER A , Porter D, Yao Y, Borawski J, et al
    A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.
    Cancer Res. 2007;67:11493-8.
    PubMed     Related articles    Abstract available
    
    
    
33. ZHANG Z , Borecki I, Nguyen L, Ma D, et al
    CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
    Cancer Res. 2007;67:11202-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
34. HALDER J , Lin YG, Merritt WM, Spannuth WA, et al
    Therapeutic Efficacy of a Novel Focal Adhesion Kinase Inhibitor TAE226 in Ovarian Carcinoma.
    Cancer Res. 2007;67:10976-10983.
    PubMed     Related articles    Abstract available
    
    
    
35. SCHOMBER T , Kopfstein L, Djonov V, Albrecht I, et al
    Placental Growth Factor-1 Attenuates Vascular Endothelial Growth Factor-A Dependent Tumor Angiogenesis during {beta} Cell Carcinogenesis.
    Cancer Res. 2007;67:10840-10848.
    PubMed     Related articles    Abstract available
    
    
    
36. YOKOYAMA Y , Sedgewick G, Ramakrishnan S
    Endostatin Binding to Ovarian Cancer Cells Inhibits Peritoneal Attachment and Dissemination.
    Cancer Res. 2007;67:10813-10822.
    PubMed     Related articles    Abstract available
    
    
    
37. VISWANATHAN AN , Hankinson SE, Schernhammer ES
    Night Shift Work and the Risk of Endometrial Cancer.
    Cancer Res. 2007;67:10618-10622.
    PubMed     Related articles    Abstract available
    
    
    
38. LANDEN CN JR , Lin YG, Armaiz Pena GN, Das PD, et al
    Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer.
    Cancer Res. 2007;67:10389-10396.
    PubMed     Related articles    Abstract available
    
    
    
39. CHEN Y , Tang Y, Wang MT, Zeng S, et al
    Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer.
    Cancer Res. 2007;67:10361-10367.
    PubMed     Related articles    Abstract available
    
    
    
40. OKTEM O , Oktay K
    A Novel Ovarian Xenografting Model to Characterize the Impact of Chemotherapy Agents on Human Primordial Follicle Reserve.
    Cancer Res. 2007;67:10159-10162.
    PubMed     Related articles    Abstract available
    
    
    
41. LU L , Katsaros D, Rigault de la Longrais IA, Sochirca O, et al
    Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable Prognosis.
    Cancer Res. 2007;67:10117-10122.
    PubMed     Related articles    Abstract available
    
    
    
42. ZHAI Y , Kuick R, Nan B, Ota I, et al
    Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion.
    Cancer Res. 2007;67:10163-72.
    PubMed     Related articles    Abstract available
    
    
    October 2007
43. CHANG CL , Tsai YC, He L, Wu TC, et al
    Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.
    Cancer Res. 2007;67:10047-57.
    PubMed     Related articles    Abstract available
    
    
    
44. HAMPEL H , Panescu J, Lockman J, Sotamaa K, et al
    Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients.
    Cancer Res. 2007;67:9603.
    PubMed     Related articles   
    
    
    
45. KOSLOWSKI M , Sahin U, Mitnacht-Kraus R, Seitz G, et al
    A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.
    Cancer Res. 2007;67:9528-34.
    PubMed     Related articles    Abstract available
    
    
    
46. KIM TJ , Ravoori M, Landen CN, Kamat AA, et al
    Antitumor and Antivascular Effects of AVE8062 in Ovarian Carcinoma.
    Cancer Res. 2007;67:9337-45.
    PubMed     Related articles    Abstract available
    
    
    
47. RAVIKUMAR S , Perez-Liz G, Del Vale L, Soprano DR, et al
    Insulin Receptor Substrate-1 Is an Important Mediator of Ovarian Cancer Cell Growth Suppression by All-trans Retinoic Acid.
    Cancer Res. 2007;67:9266-75.
    PubMed     Related articles    Abstract available
    
    
    
48. GRANOT D , Addadi Y, Kalchenko V, Harmelin A, et al
    In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors.
    Cancer Res. 2007;67:9180-9.
    PubMed     Related articles    Abstract available
    
    
    
49. HIGASHIKAWA K , Yoneda S, Tobiume K, Taki M, et al
    Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma.
    Cancer Res. 2007;67:9207-13.
    PubMed     Related articles    Abstract available
    
    
    September 2007
50. KRYCZEK I , Wei S, Zhu G, Myers L, et al
    Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma.
    Cancer Res. 2007;67:8900-5.
    PubMed     Related articles    Abstract available
    
    
    
51. IORIO MV , Visone R, Di Leva G, Donati V, et al
    MicroRNA Signatures in Human Ovarian Cancer.
    Cancer Res. 2007;67:8699-8707.
    PubMed     Related articles    Abstract available
    
    
    
52. STAVENHAGEN JB , Gorlatov S, Tuaillon N, Rankin CT, et al
    Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Cancer Res. 2007;67:8882-90.
    PubMed     Related articles    Abstract available
    
    
    
53. BERRAONDO P , Nouze C, Preville X, Ladant D, et al
    Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.
    Cancer Res. 2007;67:8847-55.
    PubMed     Related articles    Abstract available
    
    
    
54. LI X , Shen L, Zhang J, Su J, et al
    Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
    Cancer Res. 2007;67:8716-24.
    PubMed     Related articles    Abstract available
    
    
    
55. CORNEY DC , Flesken-Nikitin A, Godwin AK, Wang W, et al
    MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Cancer Res. 2007;67:8433-8.
    PubMed     Related articles    Abstract available
    
    
    
56. TSUDA N , Chang DZ, Mine T, Efferson C, et al
    Taxol increases the amount and T cell activating ability of self-immune stimulatory multimolecular complexes found in ovarian cancer cells.
    Cancer Res. 2007;67:8378-87.
    PubMed     Related articles    Abstract available
    
    
    August 2007
57. WEI S , Kryczek I, Edwards RP, Zou L, et al
    Interleukin-2 Administration Alters the CD4+FOXP3+ T-Cell Pool and Tumor Trafficking in Patients with Ovarian Carcinoma.
    Cancer Res. 2007;67:7487-94.
    PubMed     Related articles    Abstract available
    
    
    
58. SATPATHY M , Cao L, Pincheira R, Emerson R, et al
    Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
    Cancer Res. 2007;67:7194-202.
    PubMed     Related articles    Abstract available
    
    
    
59. KIKUCHI R , Tsuda H, Kanai Y, Kasamatsu T, et al
    Promoter Hypermethylation Contributes to Frequent Inactivation of a Putative Conditional Tumor Suppressor Gene Connective Tissue Growth Factor in Ovarian Cancer.
    Cancer Res. 2007;67:7095-7105.
    PubMed     Related articles    Abstract available
    
    
    
60. LI B , Allendorf DJ, Hansen R, Marroquin J, et al
    Combined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55.
    Cancer Res. 2007;67:7421-30.
    PubMed     Related articles    Abstract available
    
    
    
61. JACQUEMONT C , Taniguchi T
    Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
    Cancer Res. 2007;67:7395-405.
    PubMed     Related articles    Abstract available
    
    
    
62. GIUS D , Funk MC, Chuang EY, Feng S, et al
    Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates.
    Cancer Res. 2007;67:7113-23.
    PubMed     Related articles    Abstract available
    
    
    July 2007
63. MONGE M , Colas E, Doll A, Gonzalez M, et al
    ERM/ETV5 Up-regulation Plays a Role during Myometrial Infiltration through Matrix Metalloproteinase-2 Activation in Endometrial Cancer.
    Cancer Res. 2007;67:6753-9.
    PubMed     Related articles    Abstract available
    
    
    
64. BROWN K , Tompkins EM, Boocock DJ, Martin EA, et al
    Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose.
    Cancer Res. 2007;67:6995-7002.
    PubMed     Related articles    Abstract available
    
    
    
65. ROSANO L , Di Castro V, Spinella F, Tortora G, et al
    Combined targeting of endothelin a receptor and epidermal growth factor receptor in ovarian cancer shows enhanced antitumor activity.
    Cancer Res. 2007;67:6351-9.
    PubMed     Related articles    Abstract available
    
    
    
66. VENERE M , Snyder A, Zgheib O, Halazonetis TD, et al
    Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Cancer Res. 2007;67:6100-5.
    PubMed     Related articles    Abstract available
    
    
    
67. LUI WO , Pourmand N, Patterson BK, Fire A, et al
    Patterns of known and novel small RNAs in human cervical cancer.
    Cancer Res. 2007;67:6031-43.
    PubMed     Related articles    Abstract available
    
    
    June 2007
68. ROBINSON-SMITH TM , Isaacsohn I, Mercer CA, Zhou M, et al
    Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
    Cancer Res. 2007;67:5708-16.
    PubMed     Related articles    Abstract available
    
    
    
69. TUVE S , Chen BM, Liu Y, Cheng TL, et al
    Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.
    Cancer Res. 2007;67:5929-39.
    PubMed     Related articles    Abstract available
    
    
    
70. DAIKOKU T , Tranguch S, Chakrabarty A, Wang D, et al
    Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-{delta} Signaling in Epithelial Ovarian Cancer.
    Cancer Res. 2007;67:5285-92.
    PubMed     Related articles    Abstract available
    
    
    May 2007
71. HEMPEL N , How T, Dong M, Murphy SK, et al
    Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion.
    Cancer Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. BARBER A , Zhang T, Demars LR, Conejo-Garcia J, et al
    Chimeric NKG2D Receptor-Bearing T Cells as Immunotherapy for Ovarian Cancer.
    Cancer Res. 2007;67:5003-8.
    PubMed     Related articles    Abstract available
    
    
    
73. CHEN Y , Clark S, Wong T, Chen Y, et al
    Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models.
    Cancer Res. 2007;67:4924-32.
    PubMed     Related articles    Abstract available
    
    
    
74. BAK SP , Walters JJ, Takeya M, Conejo-Garcia JR, et al
    Scavenger receptor-a-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.
    Cancer Res. 2007;67:4783-9.
    PubMed     Related articles    Abstract available
    
    
    
75. PYEON D , Newton MA, Lambert PF, den Boon JA, et al
    Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers.
    Cancer Res. 2007;67:4605-19.
    PubMed     Related articles    Abstract available
    
    
    
76. VAN VLERKEN LE , Duan Z, Seiden MV, Amiji MM, et al
    Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
    Cancer Res. 2007;67:4843-50.
    PubMed     Related articles    Abstract available
    
    
    
77. MASOJC B , Medrek K, Debniak T, Lubinski J, et al
    ARLTS1 Trp149Stop Mutation and the Risk of Ovarian Cancer.
    Cancer Res. 2007;67:4533.
    PubMed     Related articles   
    
    
    
78. DARCY KM , Tian C, Reed E
    A Gynecologic Oncology Group Study of Platinum-DNA Adducts and Excision Repair Cross-Complementation Group 1 Expression in Optimal, Stage III Epithelial Ovarian Cancer Treated with Platinum-Taxane Chemotherapy.
    Cancer Res. 2007;67:4474-81.
    PubMed     Related articles    Abstract available
    
    
    
79. TESFAYE A , Di Cello F, Hillion J, Ronnett BM, et al
    The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.
    Cancer Res. 2007;67:3998-4004.
    PubMed     Related articles    Abstract available
    
    
    April 2007
80. SUBBARAMAIAH K , Dannenberg AJ
    Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Cancer Res. 2007;67:3976-85.
    PubMed     Related articles    Abstract available
    
    
    
81. SCHUMACHER JJ , Dings RP, Cosin J, Subramanian IV, et al
    Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
    Cancer Res. 2007;67:3683-90.
    PubMed     Related articles    Abstract available
    
    
    
82. MALONEY A , Clarke PA, Naaby-Hansen S, Stein R, et al
    Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Cancer Res. 2007;67:3239-53.
    PubMed     Related articles    Abstract available
    
    
    
83. NANJUNDAN M , Nakayama Y, Cheng KW, Lahad J, et al
    Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer.
    Cancer Res. 2007;67:3074-84.
    PubMed     Related articles    Abstract available
    
    
    
84. BEHBAKHT K , Qamar L, Aldridge CS, Coletta RD, et al
    Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.
    Cancer Res. 2007;67:3036-42.
    PubMed     Related articles    Abstract available
    
    
    
85. GAYTHER SA , Song H, Ramus SJ, Kjaer SK, et al
    Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
    Cancer Res. 2007;67:3027-35.
    PubMed     Related articles    Abstract available
    
    
    
86. ZHOU W , Han WF, Landree LE, Thupari JN, et al
    Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells.
    Cancer Res. 2007;67:2964-71.
    PubMed     Related articles    Abstract available
    
    
    March 2007
87. SWISHER EM , King MC
    Defining women at high risk of ovarian cancer.
    Cancer Res. 2007;67:2902.
    PubMed     Related articles   
    
    
    
88. HAMA Y , Urano Y, Koyama Y, Kamiya M, et al
    A target cell-specific activatable fluorescence probe for in vivo molecular imaging of cancer based on a self-quenched avidin-rhodamine conjugate.
    Cancer Res. 2007;67:2791-9.
    PubMed     Related articles    Abstract available
    
    
    
89. TOLMACHEV V , Orlova A, Pehrson R, Galli J, et al
    Radionuclide therapy of HER2-positive microxenografts using a 177Lu-labeled HER2-specific Affibody molecule.
    Cancer Res. 2007;67:2773-82.
    PubMed     Related articles    Abstract available
    
    
    
90. JACOBS S , Thompson ER, Nannya Y, Yamamoto G, et al
    Genome-wide, high-resolution detection of copy number, loss of heterozygosity, and genotypes from formalin-fixed, paraffin-embedded tumor tissue using microarrays.
    Cancer Res. 2007;67:2544-51.
    PubMed     Related articles    Abstract available
    
    
    
91. MABUCHI S , Altomare DA, Connolly DC, Klein-Szanto A, et al
    RAD001 (Everolimus) Delays Tumor Onset and Progression in a Transgenic Mouse Model of Ovarian Cancer.
    Cancer Res. 2007;67:2408-13.
    PubMed     Related articles    Abstract available
    
    
    
92. ORLOVA A , Tolmachev V, Pehrson R, Lindborg M, et al
    Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors.
    Cancer Res. 2007;67:2178-86.
    PubMed     Related articles    Abstract available
    
    
    
93. SYMOWICZ J , Adley BP, Gleason KJ, Johnson JJ, et al
    Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
    Cancer Res. 2007;67:2030-9.
    PubMed     Related articles    Abstract available
    
    
    
94. MORENO-BUENO G , Fernandez-Marcos PJ, Collado M, Tendero MJ, et al
    Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.
    Cancer Res. 2007;67:1927-34.
    PubMed     Related articles    Abstract available
    
    
    
95. KIRMA N , Hammes LS, Liu YG, Nair HB, et al
    Elevated Expression of the Oncogene c-fms and Its Ligand, the Macrophage Colony-Stimulating Factor-1, in Cervical Cancer and the Role of Transforming Growth Factor-{beta}1 in Inducing c-fms Expression.
    Cancer Res. 2007;67:1918-26.
    PubMed     Related articles    Abstract available
    
    
    September 2006
96. SUNDE JS , Donninger H, Wu K, Johnson ME, et al
    Expression Profiling Identifies Altered Expression of Genes That Contribute to the Inhibition of Transforming Growth Factor-{beta} Signaling in Ovarian Cancer.
    Cancer Res. 2006;66:8404-12.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    August 2006
97. KIM KS , Sengupta S, Berk M, Kwak YG, et al
    Hypoxia Enhances Lysophosphatidic Acid Responsiveness in Ovarian Cancer Cells and Lysophosphatidic Acid Induces Ovarian Tumor Metastasis In vivo.
    Cancer Res. 2006;66:7983-90.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: